HopeStage
Back to all studies
CompletedNCT03143855

Lorcaserin and Oxycodone Effects in People With Opioid Use Disorder

About this title

Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder

Read the official source — NCT03143855
Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
RichmondSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 30, 2017
Recruitment status
Completed
Enrollment listed in the registry
32
Sponsor
Virginia Commonwealth University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT03143855
Official title
Show the full official title

Phase I Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Richmond

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Virginia Commonwealth University, a university.

Did this study involve medication?

Yes. The study involved medication, including Lorcaserin and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies